Advanced Search

 

Study ID Status Title Patient Level Data
SCA104779 Completed Study SCA104779, an evaluation of BW430C (lamotrigine) versus placebo in the prevention of mood episodes in bipolar I disorder patients Study Listed on ClinicalStudyDataRequest.com
SCA106052 Completed Study SCA106052, a clinical evaluation of BW430C (lamotrigine) in bipolar I disorder– Long-term extension study (extension of study SCA104779 (NCT00550407)) Study Listed on ClinicalStudyDataRequest.com
SCA10908 Completed A randomised, partially blinded, parallel group study to investigate the potential pharmacokinetic interaction between lamotrigine and olanzapine in healthy, non-smoking, male volunteers. Study Listed on ClinicalStudyDataRequest.com
SCA10910 Completed A randomised, partially blinded, parallel group study to investigate the potential pharmacokinetic interaction between lamotrigine and oxcarbazepine in healthy, non-smoking, male volunteers. Study Listed on ClinicalStudyDataRequest.com
SCA20022 Completed Title A Randomized, Multicenter, Double–Blind, Placebo–Controlled, Fixed–Dose, 7–Week Evaluation of the Efficacy and Safety of Lamotrigine in Patients with Major Depression
SCA20025 Completed A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Fixed-Dose 7-Week Evaluation of theEfficacy and Safety of Lamotrigine in Treatment of a Major Depressive Episode in Unipolar DepressedPatients
SCA30905 Completed See Detailed Description
SCA30923 Completed An open, prospective study of the effectiveness of lamotrigine in the prevention of recurrence in bipolar affective disorder
SCA30924 Completed Double blind placebo controlled study of lamictal in acute bipolar depression Study Listed on ClinicalStudyDataRequest.com
SCA30926 Completed A Multi-Center, Double blind, Placebo-controlled, Randomized, Parallel Group Evaluation of the Efficacy of a Flexible Dose of Lamotrigine versus Placebo As Add-On Therapy In Schizophrenia Study Listed on ClinicalStudyDataRequest.com
SCA40910 Completed A Multicenter, Double-Blind, Placebo-Controlled, Fixed-Dose Evaluation of the Safety, Efficacy, and Tolerability of LAMICTAL (Lamotrigine) in the Treatment of a Major Depressive Episode in Patients with Type I Bipolar Disorder Study Listed on ClinicalStudyDataRequest.com
SCA40917 Completed Lamictal for use in treatment of Bipolar Disorder In Adults. A Practical Clinical Assessment of Tolerability and Clinical Effectiveness. Study Listed on ClinicalStudyDataRequest.com
SCAA1001 Completed A Randomized, Crossover Study to Evaluate the Pharmacokinetic Effect of Multiple Doses of Bupropion Hydrochloride (WELLBUTRIN SR) on a Single Oral Dose of Lamotrigine (LAMICTAL)
SCAA2008 Completed A 3 Week Multicenter, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of LAMICTAL (lamotrigine) Compared to Placebo in the Treatment of An Acute Manic or Mixed Episode in Patients who have Bipolar Disorder
SCAA2010 Completed A Multicenter, Double–Blind, Placebo–Controlled, Flexible Dose (100–400mg) 10 Week EvaluationOf the Safety and Efficacy of LAMICTAL (Lamotrigine) in the Treatment of a Major Depressive Episode inPatients with Bipolar Disorder
SCAA2011 Completed SCAA2011 (105-613): An Eight Week, Multicenter, Double-Blind, Randomized, Fixed-Dose Evaluation of the Efficacy and Safety of Lamotrigine (200mg/day), Desipramine (200mg/day), and Placebo in Outpatients with Unipolar Depression
SCAA2012 Completed A Multicenter, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Evaluation of the Safety and Efficacy of Lamotrigine in the Long-Term Prevention of Mood Episodes in Patients with Bipolar Disorder with Rapid Cycling
SCAA2014 Completed SCAA2014: A 52 Week, Open, Multicenter, Flexible-Dose Continuation Study of LAMICTAL (lamotrigine) in Patients with Bipolar Disorder Who Have Completed Protocol SCAA2010
SCAA4001 Completed A Double-blind, Double-dummy, Parallel-group Comparison of Lamotrigine and Divalproex Sodium Initial Monotherapy in Patients with Epilepsy Study Listed on ClinicalStudyDataRequest.com
SCAB1001 Completed (SCAB1001): Report for a study to investigate whether multiple oral doses of lamotrigine affect the pharmacokinetic of multiple oral doses of Lithium in healthy volunteers.
SCAB2001 Completed A Multicenter, Double–Blind, Placebo–Controlled, Fixed Dose (50 or 200mg per day) 7 Week Evaluation of the Safety and Efficacy of LAMICTAL (Lamotrigine) in the Treatment of a Major Depressive Episode in Patients Suffering From Bipolar Disorder
SCAB2002 Completed A 52 Week, Open-label, Multicenter, Flexible-Dose Continuation Study of LAMICTAL (Lamotrigine) in Patients with Bipolar Disorder
SCAB2003 Completed A Multicenter, Double-blind, Placebo-controlled, Randomized, Fixed-dose Evaluation of the Safety and Efficacy of Lamotrigine in the Long-term Prevention of Relapse and Recurrence of Depression and/or Mania in Subjects with Bipolar I Disorder Study Listed on ClinicalStudyDataRequest.com
SCAB2005 Completed A Multicenter, Double-Blind, Placebo-Controlled, Flexible-Dose Evaluation of the Safety and Efficacy of Lamotrigine in the Long Term Treatment of Subjects who have Bipolar Disorder with Rapid Cycling
SCAB2006 Completed A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Flexible-Dose Evaluation of the Safety and Efficacy of Lamotrigine in the Long-Term Prevention of Relapse and Recurrence of Mania and/or Depression in Subjects with Bipolar I Disorder

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.